Title: Changing Rules in Tort Law and the Market for Childhood Vaccines
Abstract: Previous articleNext article No AccessChanging Rules in Tort Law and the Market for Childhood VaccinesRichard L ManningRichard L ManningPDFPDF PLUS Add to favoritesDownload CitationTrack CitationsPermissionsReprints Share onFacebookTwitterLinkedInRedditEmail SectionsMoreDetailsFiguresReferencesCited by The Journal of Law and Economics Volume 37, Number 1Apr., 1994 Sponsored by The University of Chicago Booth School of Business and The University of Chicago Law School Article DOIhttps://doi.org/10.1086/467313 Views: 11Total views on this site Citations: 25Citations are reported from Crossref Copyright 1994 The University of ChicagoPDF download Crossref reports the following articles citing this article:David I. Benbow Virtue ethics and the United Kingdom (UK) Vaccine Damage Payment Scheme (VDPS), Journal of Social Welfare and Family Law 44, no.33 (Aug 2022): 391–410.https://doi.org/10.1080/09649069.2022.2102759Richard Goldberg Vaccine damage schemes in the US and UK reappraised: making them fit for purpose in the light of Covid-19, Legal Studies 97 (Mar 2022): 1–24.https://doi.org/10.1017/lst.2022.9Margaret K. Kyle The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals, Innovation Policy and the Economy 20 (Dec 2019): 95–123.https://doi.org/10.1086/705640Min Zhou, Shujuan Qu, Lindu Zhao, Nan Kong, Kathryn S. Campy, Song Wang Trust collapse caused by the Changsheng vaccine crisis in China, Vaccine 37, no.2626 (Jun 2019): 3419–3425.https://doi.org/10.1016/j.vaccine.2019.05.020Gayle DeLong Is “Delitigation” Associated with a Change in Product Safety? The Case of Vaccines, Review of Industrial Organization 52, no.11 (Jun 2017): 1–53.https://doi.org/10.1007/s11151-017-9579-7Gayle DeLong Can ‘delitigation’ transform an industry?, The Quarterly Review of Economics and Finance 67 (Feb 2018): 245–254.https://doi.org/10.1016/j.qref.2017.07.001Juan Camilo Serpa, Harish Krishnan Policy Incentives for Dangerous (But Necessary) Operations, Production and Operations Management 25, no.1010 (Aug 2016): 1778–1798.https://doi.org/10.1111/poms.12597Kristina M. Lybecker, Lachlan Watkins Liability risk in the pharmaceutical industry: Tort law in the US and UK, The Social Science Journal 52, no.44 (Dec 2019): 433–448.https://doi.org/10.1016/j.soscij.2014.03.010J. Mark Ramseyer Liability for Defective Products: Comparative Hypotheses and Evidence from Japan, American Journal of Comparative Law 61, no.33 (Jul 2013): 617–655.https://doi.org/10.5131/AJCL.2012.0026Juan Camilo Serpa, Harish Krishnan It's a Dangerous Job, But Someone's Got to Do it: Policy Incentives to Mitigate the Impact of Operational Tort Liability, SSRN Electronic Journal (Jan 2013).https://doi.org/10.2139/ssrn.2389815J. Mark Ramseyer Products Liability and Product Safety: Japan and the U.S., SSRN Electronic Journal (Jan 2012).https://doi.org/10.2139/ssrn.2084077Patricia M. Danzon, Nuno Sousa Pereira Vaccine Supply: Effects of Regulation and Competition, International Journal of the Economics of Business 18, no.22 (Jul 2011): 239–271.https://doi.org/10.1080/13571516.2011.584429A. F. Del Rossi, W. K. Viscusi The Changing Landscape of Blockbuster Punitive Damages Awards, American Law and Economics Review 12, no.11 (Dec 2009): 116–161.https://doi.org/10.1093/aler/ahp018Anupam B. Jena, Tomas J. Philipson Cost-effectiveness analysis and innovation, Journal of Health Economics 27, no.55 (Sep 2008): 1224–1236.https://doi.org/10.1016/j.jhealeco.2008.05.010Tomas J Philipson, Eric Sun Is the Food and Drug Administration Safe and Effective?, Journal of Economic Perspectives 22, no.11 (Feb 2008): 85–102.https://doi.org/10.1257/jep.22.1.85 Paul H. Rubin and Joanna M. Shepherd Tort Reform and Accidental Deaths Rubin/Shepherd, The Journal of Law and Economics 50, no.22 (Jul 2015): 221–238.https://doi.org/10.1086/521738Daniel P. Kessler, Daniel L. Rubinfeld Chapter 5 Empirical Study of the Civil Justice System, (Jan 2007): 343–402.https://doi.org/10.1016/S1574-0730(07)01005-5W. Kip Viscusi Chapter 9 Regulation of Health, Safety, and Environmental Risks, (Jan 2007): 591–645.https://doi.org/10.1016/S1574-0730(07)01009-2W. Kip Viscusi Regulation of Health, Safety, and Environmental Risks, SSRN Electronic Journal (Jan 2006).https://doi.org/10.2139/ssrn.921426F.M. Scherer Chapter 25 The pharmaceutical industry, (Jan 2000): 1297–1336.https://doi.org/10.1016/S1574-0064(00)80038-4Paul H. Rubin Treatment Decisions: Tort or Contract, SSRN Electronic Journal (Jan 1999).https://doi.org/10.2139/ssrn.157358Paul H. Rubin Courts and the Tort-Contract Boundary in Product Liability, SSRN Electronic Journal (Jan 1999).https://doi.org/10.2139/ssrn.157359 By Richard L Manning Products Liability and Prescription Drug Prices in Canada and the United States Manning, The Journal of Law and Economics 40, no.11 (Jul 2015): 203–244.https://doi.org/10.1086/467371Clive D. Fraser On tort as an implicit insurance system with state-dependent utility: The case of child mortality risk, International Review of Law and Economics 16, no.44 (Dec 1996): 449–459.https://doi.org/10.1016/S0144-8188(96)00037-3Richard L Manning Is the insurance aspect of producer liability valued by consumers? Liability changes and childhood vaccine consumption, Journal of Risk and Uncertainty 13, no.11 (Jul 1996): 37–51.https://doi.org/10.1007/BF00055337
Publication Year: 1994
Publication Date: 1994-04-01
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
Cited By Count: 48
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot